Crédit Industriel et Commercial’s Mersana Therapeutics MRSN Stock Holding History

Crédit Industriel et Commercial’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,392	Closed	-$1.2M	–	410
2025 Q4	$1.2M	Buy	+41,392	New	+$786K	0.09%	216

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crédit Industriel et Commercial's MRSN Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 41,392 shares — an estimated $1.2M sold.

Crédit Industriel et Commercial first reported a position in MRSN in Q4 2025 and held it in 1 quarter. The position peaked at $1.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

Crédit Industriel et Commercial reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 41,392 Mersana Therapeutics shares in Q1 2026, an estimated $1.2M.
Crédit Industriel et Commercial first reported a position in Mersana Therapeutics in Q4 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Mersana Therapeutics position peaked at $1.2M in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.